Related Experiment Video

Updated: Jun 5, 2025

Platelet-Rich Plasma Lysate for Treatment of Eye Surface Diseases
05:57

Platelet-Rich Plasma Lysate for Treatment of Eye Surface Diseases

Published on: August 2, 2022

4.0K

Pipeline: Pricing for drugs treating dry eye disease

S Osman Hussain1, Gary D Novack2

  • 1RHMM Inc, Larkspur, CA, USA.

The Ocular Surface
|December 14, 2024
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Author Spotlight: Exploring Press Needle Efficacy and Underlying Molecular Pathways
05:26

Author Spotlight: Exploring Press Needle Efficacy and Underlying Molecular Pathways

Published on: April 12, 2024

1.2K
Intense Pulsed Light for the Treatment of Dry Eye Owing to Meibomian Gland Dysfunction
05:00

Intense Pulsed Light for the Treatment of Dry Eye Owing to Meibomian Gland Dysfunction

Published on: April 1, 2019

14.9K

Related Experiment Videos

Last Updated: Jun 5, 2025

Platelet-Rich Plasma Lysate for Treatment of Eye Surface Diseases
05:57

Platelet-Rich Plasma Lysate for Treatment of Eye Surface Diseases

Published on: August 2, 2022

4.0K
Author Spotlight: Exploring Press Needle Efficacy and Underlying Molecular Pathways
05:26

Author Spotlight: Exploring Press Needle Efficacy and Underlying Molecular Pathways

Published on: April 12, 2024

1.2K
Intense Pulsed Light for the Treatment of Dry Eye Owing to Meibomian Gland Dysfunction
05:00

Intense Pulsed Light for the Treatment of Dry Eye Owing to Meibomian Gland Dysfunction

Published on: April 1, 2019

14.9K

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

391
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
391
Drug Delivery: Miscellaneous Routes01:22

Drug Delivery: Miscellaneous Routes

315
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
315

Articles linked to this work by shared authors, journal, and citation graph.

Use of Clinical Pharmacology in Slowing the Myopia Epidemic.

Clinical pharmacology and therapeutics·2026

Double-Masked Controlled Trial of H-1337 as a Treatment for Glaucoma and Ocular Hypertension.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics·2025

Ocular Surface Damage and Blink Dynamics Associated with High-intensity Smartphone Use.

The ocular surface·2026

Male predominance and pubertal resolution in vernal Keratoconjunctivitis: Exploring associations with ocular surface sex steroid intracrinology.

The ocular surface·2026

Longitudinal, prospective evaluation of inflammatory tear cytokine ratios and their association with ocular surface disease.

The ocular surface·2026

The Hippo signaling pathway regulates corneal endothelial regeneration.

The ocular surface·2026

Integrated tear vitamin D-IL-6-NRF2 signature associated with keratoconus severity: An exploratory cross-sectional study.

The ocular surface·2026

Lipocalin 2 as a novel target of pralatrexate mitigating corneal epithelial damage in a mouse model of herpes simplex keratitis.

The ocular surface·2026

Development of discriminatory and biopredictive bicarbonate buffer based dissolution method to screen delayed release formulations.

Drug development and industrial pharmacy·2026

α/β-Hydrolase domain-containing 6 (ABHD6) accelerates the desensitization and deactivation of TARP γ-2-containing AMPA receptors.

eLife·2026

Probing protein-lipid interactions by hydrogen/deuterium exchange-mass spectrometry: advances, challenges and future directions.

Chemical science·2026

Span60/Cholesterol Niosomal Formulation as a Transport Vehicle for L-DOPA and Rasagiline Delivery with Potent In Vitro Neuroprotective Effect.

Applied biochemistry and biotechnology·2026

Evaluating Powder Deposition in the Nasal Airways Using a Facile Fluorescent-Imaging Method.

Journal of aerosol medicine and pulmonary drug delivery·2026

The INTREPID program: Linking illicit fentanyl-containing tablets and powders seized at US borders to a common origin by combining physical/chemical identifiers and machine learning.

Journal of forensic sciences·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us